Journals / Dicle Tıp Dergisi / 2004 / Cilt: 31 - Sayı: 3

The effects of bleomycin on the structural abnormalities of chromosomes in smokers

Sigara tiryakilerinde bleomycin'in kromozomal düzensizliklere etkisi

Pages
50–56
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In addition due to the increases in dosage, there was an increase in structural aberration quantities and qualities.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Bleomycin in doses 0.3, 3 and 30 µg/ml was used with periods 6, 24 and 48 hours on 5 male samples who were smokers, in in-vitro conditions and under control so totally 3000 metaphases were evaluated.
📊
Key Findings & Data:Structural chromosome aberrations were influenced by the increases in dosage.
💡
Conclusion & Impact:In addition due to the increases in dosage, there was an increase in structural aberration quantities and qualities.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Bleomisin · Kromozom sapmaları · Metafaz

Abstract

Bleomycin in doses 0.3, 3 and 30 µg/ml was used with periods 6, 24 and 48 hours on 5 male samples who were smokers, in in-vitro conditions and under control so totally 3000 metaphases were evaluated. Structural chromosome aberrations were influenced by the increases in dosage. While the ratio total structural aberrations to the number of metaphases examined was 25.2% in control groups, It was 47.3% in 0.3 µg/ml group, 76% in 3 µg/ml and rose up to 116.8% in 30 µg/ml experiment group. In addition due to the increases in dosage, there was an increase in structural aberration quantities and qualities.

Özet

Bu çalışmada yaşları 25-30 arasında değişen ve ortalama olarak günde 40 sigara içen 5 erkek bireyde bleomycin'in kromozomlar üzerindeki etkisi araştırıldı. Deneklere ait periferik kanda 0.3 µg/ml, 3 µg/ml ve 30 µg/ml dozunda bleomycin 6, 24 ve 48 saat süre ile in-vitro koşullarda uygulanarak yapılan lenfosit kültüründe, toplam 3000 metafaz incelenmiştir. Yapısal kromozom düzensizlikleri artan bleomycin dozunun artışı ile pozitif yönde etkilenmektedir. Toplam yapısal kromozom düzensizliklerinin incelenen metafaz sayısına oranı kontrol gruplarında %25.2 iken, 0.3 µg/ml bleomycin dozunda %47.3, 3 µg/ml Bleomycin dozunda %76 ve 30 µg/ml bleomycin dozunda ise %116.8 olarak bulunmuştur. Ayrıca, doz artışına paralel olarak yapısal düzensizliklerin çeşitlerinde, niteliklerinde ve oranlarında da düzenli bir artma olmaktadır.

🔖

Cite This Article

ORAL, Ö. D., İSİ, H. (2004). The effects of bleomycin on the structural abnormalities of chromosomes in smokers. Dicle Tıp Dergisi, Cilt: 31 - Sayı: 3, 50–56. https://ajindex.com/articles/349391

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (20)

  1. PekşenY., Sigara içiminin Nedenleri Epidemiyolojisi, Pasif İçicilik. İn: Ayla Tür, Sigaranın Sağlığa Etkileri ve Bırakma Yöntemleri, Logos Yayıncılık, 1995, 1-28
  2. The Encyclopedia Americana, Tobacco,. Grolier, USA 1982. Vol.26, p 800 3. Williand N., Third World Worning. WHO Chronicle 1983,U:37, p. 86
  3. Aşut Ö., Hekim ve Sigara, Türk Tabibler Birliği Yayınları, Nisan 1993
  4. De Vita VT, et al., Cancer, Principles of Oncology, 3rd ed. Phyladelphia JB Lippincott Co., 1989
  5. Bornstein R.S.,et al., Cytogenetic effects of bleomycin therapy in man. Cancer Res. 1971, 31: 2004-2007
  6. Cox R., Daoud A.H., Irving C.C., Damage of rat liver decoxyribonucleic acid by bleomycin. Biochem. Pharmachol.1974, 23: 3147-3151
  7. Croore S.T. and Bradner W.T., Bleomycin, A reviem. Journal of Medicine, 1976, 7 (5): 333-429
  8. Goodman – Gilman A. Et al., The pharmacological Basis of Therapeutics. Eight Edition, Pergamon Pres. Inc. 1990
  9. Moorhead PS., Novel PC., Moolman WS., et all., Chromosome preparation of leucocytes cultured from human peripheral blood. Exp. Cell Res. 1961, 20:613-616
  10. Başaran N., Tıbbi Genetik Ders Kitabı 4. Baskı. Bilim ve Teknik Yayınevi. Eskişehir.1986
  11. Mueller RF., Young ID., Emery’s Elements of Medical Genetics. Tenth Ed. Churchill Livingstone.1998
  12. Şaylı BS., Medikal Genetik Teorik ve Klinik Sitogenetik 4. Baskı. Ankara ÜniversitesiTıp Fakültesi Yayını Sayı 381. Ankara 1979
  13. Gustashaw KM., Chromosome Stains. İn: Barch Margaret J.: The Acts Cytogenetics Laboratuary Manual Second Ed. Ravend Press. New York. 1991-205-269
  14. Rooney DE., Czepukowski BH. Human Cytogenetics. Volum ll: 1-25. Oxford University Press. New York.1992
  15. Lüleci G., Başaran S., Bağcı G., Keser İ., Sitogenetik Uygulama Yöntemleri. Metaksan A.Ş.Ankara.1990. 1-50
  16. Yurtseven N., Deneysel İstatistiksel Metotlar. Tarım Orman ve Köy İşleri Bakanlığı Köy Hizmetleri Genel Müdürlüğü Toprak ve Gübre Araştırma Enstitüsü Yayınları Teknik Yayın No: 56: 90-313. Ankara.1984
  17. Promchainant C., Cytogenetic effect of Bleomycin on human leucocytes in-vitro. Mutat Res 1975, 28: 107-112
  18. Vijayelexmi and Evans H.J., In in-vivo and in-vitro effects of cigarette smoke on chromosomal damage and SCE in human peripheral blood lymphocytes. Mutation Research. 1982, 92: 321-325
  19. Litlefield L.G., Toiner E.E., Analysis of chromosome aberrations in lymphocytes of lung heavy smokers. Mutation Research.1986, 170: 145-150
  20. Brinkworsth M.H., Yardley-Jones A., Edw